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Pharmacist vaccination – an Australian first, but what was the impact? 
 
Introduction/background/issues 
The Queensland Pharmacist Immunisation Pilot is Australia’s first to allow pharmacists 
vaccination. The pilot ran between April 1st 2014 and August 31st 2014, with pharmacists 
administering influenza vaccination during the flu season. The aim of this work was to 
investigate the benefits of trained registered pharmacists administering vaccinations in a 
community pharmacy setting. 
 
Methods 
Participant demographics and previous influenza vaccination experiences were recorded 
using GuildCare software. Participants also completed a ‘post-vaccination satisfaction 
survey’ following their influenza vaccination. 
 
Results/discussions 
A total of 10,889 participant records were analysed. Females accounted for 63% of 
participants, with the majority of participants aged between 45-64 years (53%). Overall, 49% 
of participants had been vaccinated before, the majority at a GP clinic (60%). Most 
participants reported receiving their previous influenza vaccination from a nurse (61%). 
Interestingly, 1% thought a pharmacist had administered their previous vaccination, while 7% 
were unsure which health professional had administered it. It was also of note that 
approximately 10% of all participants were eligible to receive a free vaccination from the 
National Immunisation Program, but still opted to receive their vaccine in a pharmacy.  
Over 8,000 participants took part in the post-vaccination survey, 93% were happy to receive 
their vaccination from a pharmacy in the future while 94% would recommend this service to 
other people. The remaining 7% and 6% respectively had omitted to fill in those questions.  
 
Conclusions/implications  
These findings have helped pave the way for expanding the scope of practice for pharmacists 
with the aim to increase vaccination rates across Australia. 
 
Key message 
 Scope of practice and ability for health providers like pharmacists to provide services 
such as vaccination in primary care. 
 New service delivery to improve access to service, and increase immunisation rates. 
 
 
